New hope for tough leukemia: CAR t cell trial opens for adults

This study is testing a new type of immunotherapy called CAR T cells for adults (ages 18-75) with a hard-to-treat blood cancer called acute lymphoblastic leukemia (ALL) that has come back or not responded to standard treatments. The treatment involves taking a patient's own immune cells, modifying them in a lab to better recognize and attack cancer cells, and then giving them back. The main goal is to find the safest dose and understand side effects, while also checking if the treatment can help control the disease.